Comparative Pharmacology

Head-to-head clinical analysis: AMINOSYN II 3 5 M IN PLASTIC CONTAINER versus AMINOSYN II 4 25 IN DEXTROSE 25 IN PLASTIC CONTAINER.

Peer-Reviewed Evidence

Differential Analysis

AMINOSYN II 3.5% M IN PLASTIC CONTAINER vs AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

AMINOSYN II 3.5% M IN PLASTIC CONTAINER

Amino Acid Solution

Category C

AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER

Amino Acid Solution

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Aminosyn II 3.5% M is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance maintenance in patients unable to tolerate oral/enteral nutrition. The 'M' formulation includes electrolytes and trace elements. Amino acids are incorporated into endogenous proteins, serving as substrates for gluconeogenesis, oxidative metabolism, and neurotransmitter synthesis.

Aminosin II 4.25% in Dextrose 25% provides essential amino acids and dextrose for parenteral nutrition. Amino acids serve as building blocks for protein synthesis, while dextrose supplies a source of calories to prevent catabolism. The combination aims to maintain nitrogen balance and support metabolic functions.

Clinical Dosing

Intravenous administration; typical adult dose is 1 to 2 g amino acids/kg/day, corresponding to 30 to 60 mL/kg/day of 3.5% solution; infusion rate not to exceed 0.1 g amino acids/kg/hour.

Administer as a continuous intravenous infusion. Typical adult dose: 1.0-1.5 g amino acids/kg/day (equivalent to approximately 23-35 mL/kg/day of AMINOSYN II 4.25% in DEXTROSE 25%) via central venous line. Adjust based on metabolic needs and tolerance.

Direct Interaction

None Documented